The alternative splicing (AS) mechanism is considered the major driving force of transcriptome and proteome diversity. Itrelies on a delicate and finely tuned interplay among a great number of molecular elements. The crucial action of AS in the regulation of diverse biological processes is not limited to physiological states, but is mirrored in the growing list of human diseases associated with known or suspected splicing defects, including neurodegenerative and oncologicaldiseases. In these pathologies, the AS regulation of PARK2gene (also called parkin RBR E3 ubiquitin protein ligase), one of the largest in our genome, seems to play a fundamental role. Here, we will briefly review some major data concerning the genetic organization, the transcription regulation, the structure of the protein and the relative molecular functions of PARK2. Then we will focuson the current knowledge about PARK2 alternative spliced isoforms and their implication in human diseases

Parkin Alternative Splicing: Not Only Parkinsonism

Valentina La Cognata;Francesca Cavalcanti;Sebastiano Cavallaro
2016

Abstract

The alternative splicing (AS) mechanism is considered the major driving force of transcriptome and proteome diversity. Itrelies on a delicate and finely tuned interplay among a great number of molecular elements. The crucial action of AS in the regulation of diverse biological processes is not limited to physiological states, but is mirrored in the growing list of human diseases associated with known or suspected splicing defects, including neurodegenerative and oncologicaldiseases. In these pathologies, the AS regulation of PARK2gene (also called parkin RBR E3 ubiquitin protein ligase), one of the largest in our genome, seems to play a fundamental role. Here, we will briefly review some major data concerning the genetic organization, the transcription regulation, the structure of the protein and the relative molecular functions of PARK2. Then we will focuson the current knowledge about PARK2 alternative spliced isoforms and their implication in human diseases
2016
Istituto di Scienze Neurologiche - ISN - Sede Mangone
Istituto di Scienze Neurologiche - ISN - Sede Mangone
PARK2
parkin
alternative splicing
Parkinson's disease
cancer
File in questo prodotto:
File Dimensione Formato  
prod_356203-doc_115847.pdf

non disponibili

Descrizione: Parkin Alternative Splicing: Not Only Parkinsonism
Tipologia: Versione Editoriale (PDF)
Dimensione 426.1 kB
Formato Adobe PDF
426.1 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/318494
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact